Cutaneous manifestations of pituitary gland diseases

Clinics in Dermatology

Volumn 26, Issue 3, 2008, Pages 288-295

  Davidovici, Batya B ^a   Orion, Edith ^a   Wolf, Ronni ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CORTICOTROPIN; CYPROHEPTADINE; GLUCOCORTICOID; GLUTETHIMIDE; GONADOTROPIN; GROWTH HORMONE; INTERMEDIN; KETOCONAZOLE; METYRAPONE; MINERALOCORTICOID; OCTREOTIDE; PHENOTHIAZINE; PROLACTIN; SOMATOMEDIN B; SOMATOMEDIN C; STEROID; THYROTROPIN; THYROXINE;

ACNE VULGARIS; ACROMEGALY; ADRENALECTOMY; ALOPECIA; ARTICLE; ATOPIC DERMATITIS; CHIARI FROMMEL SYNDROME; CLINICAL FEATURE; CUSHING DISEASE; DISEASE COURSE; DRUG MEGADOSE; GONADOTROPIN RELEASE; HIRSUTISM; HORMONE RELEASE; HUMAN; HYPERADRENOCORTICISM; HYPERPROLACTINEMIA; HYPERTRICHOSIS; HYPOPHYSIS DISEASE; HYPOPITUITARISM; MICROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PIGMENT DISORDER; POIKILODERMA; PRIORITY JOURNAL; PROLACTINOMA; PSORIASIS; SKIN MANIFESTATION; SURGICAL TECHNIQUE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

CUSHING SYNDROME; FEMALE; HUMANS; PITUITARY DISEASES; SKIN DISEASES;

EID: 47149103125     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2007.10.016     Document Type: Article

References (60)

1. Brada M., Rajan B., Traish D., et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 38 (1993) 571-578
2. Barrande G., Pittino-Lungo M., Coste J., et al. Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab 85 (2000) 3779-3785
3. Minniti G., Jaffrain-Rea M.L., Osti M., et al. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clin Endocrinol (Oxf) 62 (2005) 210-216
4. Brada M., Ashley S., Ford D., Traish D., Burchell L., and Rajan B. Cerebrovascular mortality in patients with pituitary adenoma. Clin Endocrinol (Oxf) 57 (2002) 713-717
5. Thorner M.O., Vance M.L., Laws E.R., et al. The anterior pituitary. In: Wilson J.D., Foster D.W., Kronenberg H.M., et al. (Eds). Williams textbook of endocrinology. 9th ed. (1998), WB Saunders, Philadelphia 295-307
6. Van Wyk J.J., and Underwood L.E. Relation between growth hormone and somatomedin. Annu Rev Med 26 (1975) 427-441
7. Matsuoka L.Y., Wortsman J., Kupchella C.E., et al. Histochemical characterization of the cutaneous involvement of acromegaly. Arch Intern Med 142 (1982) 1820-1823
8. Mekamed S. Clinical manifestations of acromegaly. UpToDate 6 (1998) 1-5
9. MacFarlane I.A., Knass D., Beardwell C.G., et al. Hyperhidrosis in acromegaly: effectiveness of topical aluminium chloride hexahydrate solution. Br J Med 2 (1979) 901-902
10. Burton J.L., Libman L.J., Cunliffe W.J., et al. Sebum excretion in acromegaly. Br J Med 1 (1972) 406-408
11. Chalmers R.J., Ead R.D., Beck M.H., et al. Acne vulgaris and hidradenitis suppurativa as presenting features of acromegaly. BMJ (Clin Res Ed) 287 (1983) 1346-1347
12. Brown J., Winkelmann R.K., and Randall R.V. Acanthosis nigricans and pituitary tumors, report of eight cases. JAMA 198 (1966) 619-623
13. Levin S.R., Hofeldt F.D., Becker N., et al. Hypersomatotropism and acanthosis nigricans in two brothers. Arch Intern Med 134 (1974) 365-367
14. Trouillas J., Sassolas G., Guigard M.P., et al. Relationships between pathological diagnosis and clinical parameters in acromegaly. Metab Clin Exp 45 (1996) 53-56
15. Weber G., Neidhardt M., and Schmidt A. Korrelation von Wachstumshormon und klinischem Bild der Psoriasis. Arch Dermatol Res 270 (1981) 129-140
16. Weber G., Pliess G., and Heitz U. Growth hormone producing hyperplasia of pituitary gland in psoriasis. Arch Dermatol Res 277 (1985) 345
17. Weber G., Heitz U., and Pliess G. Hyperplasia of growth hormone producing cells in the hypophysis in psoriasis, study of 10 patients. Hautarzt 37 (1986) 458-462
18. Mackie R.M., Beastall G.M., and Thomson J.A. Growth hormone levels in psoriasis. Arch Dermatol Res 275 (1984) 207-208
19. Vernier A., De Simone C., Forri L., et al. Treatment of severe psoriasis with somatostatin: four years of experience. Arch Dermatol Res 280 Suppl (1988) 51-54
20. Todd D.J., Eedy D.J., and McMillan J.C. Acromegaly and psoriasis. Clin Exp Dermatol 16 (1991) 222-223
21. Guilhou J.J. Growth hormone, somatostatin and psoriasis. Dermatologica 181 (1990) 81-82
22. Mekamed S. Diagnosis of acromegaly. UpToDate 6 (1997) 1-4
23. Ezzat S. Acromegaly. Endocrinol Metab Clin North Am 26 (1997) 703-723
24. Giustina A., Barkan A., Casanueva F.F., et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85 (2000) 526-529
25. Baldelli R., Ferretti E., Jaffrain-Rea M.L., et al. Cardiac effects of SR-lanreotide, a slow-release somatostatin analog, in acromegalic patients. J Clin Endocrinol Metab 84 (1999) 527-532
26. Amato G., Mazziotti G., Rotondi M., et al. Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. Clin Endocrinol (Oxf) 56 (2002) 65-71
27. Freda P.U. How effective are current therapies for acromegaly?. Growth Horm IGF Res 13 (2003) S144-S151
28. Meema H.E., Sheppard R.H., and Rapoport A. Roentgenographic visualization and measurement of skin thickness and its diagnostic application in acromegaly. Radiology 82 (1964) 411-417
29. Fields M.L., Greenberg B.H., and Burkett L.L. Roentgenographic measurement of skin and heel-pad thickness in the diagnosis of acromegaly. Am J Med Sci 254 (1967) 528-533
30. Gooding G.A., Stress R.M., Graf P.M., et al. Heel pad thickness: determination by high-resolution ultrasonography. J Ultrasound Med 4 (1985) 173-174
31. Lang P.G. Adrenal disorders. In: Callen J.P. (Ed). Cutaneous aspects of internal disease (1981), Year Book Medical Publishers, London 451-462
32. Deacon S.P. Pituitary-dependent Cushing's disease. BMJ 1 (1977) 1409
33. Yanovski J.A., and Cutler G.B. Glucocorticoid action and the clinical features of Cushing's syndrome. Endocrinol Metab Clin North Am 23 (1994) 487-509
34. Fisher L.B., and Maibach H.I. The effect of corticosteroids on human epidermal mitotic activity. Arch Dermatol 103 (1971) 39-44
35. Rokowski K., Sheehy J., and Cutroneo K.R. Glucocorticoid-mediated selective reduction of functioning collagen messenger ribonucleic acid. Arch Biochem Biophys 210 (1981) 74-81
36. Findling J.W., and Raff H. Diagnosis and differential diagnosis of Cushing's syndrome. Endocrinol Metab Clin North Am 30 (2001) 729-747
37. Matsuoka L.Y., Wortsman J., Gavin J.R., et al. Spectrum of endocrine abnormalities associated with acanthosis nigricans. Am J Med 83 (1987) 719-725
38. Winkelmann R.K., Scheen S.R., and Underdahl L.O. Acanthosis nigricans and endocrine disease. JAMA 174 (1960) 1145-1152
39. Freinkel R.K. Cutaneous manifestations of endocrine diseases. In: Fitzpatrick T.B., Eisen A.Z., Wolf K., et al. (Eds). Dermatology in general medicine. 4th ed. (1993), McGraw-Hill, New York 2113-2131
40. Findling J.W., and Raff H. Newer diagnostic techniques and problems in Cushing's disease. Endocrinol Metab Clin North Am 28 (1999) 191-210
41. Meier C.A., and Biller B.M. Clinical and biochemical evaluation of Cushing's syndrome. Endocrinol Metab Clin North Am 26 (1997) 741-762
42. Mampalam T.J., Tyrrell J.B., and Wilson C.B. Transsphenoidal microsurgery for Cushing disease. A report of 216 cases. Ann Intern Med 109 (1988) 487-493
43. Doyle D., and O'Donovan D.K. More on cyproheptadine in Cushing's disease (letter). N Engl J Med 296 (1977) 576
44. Jabbour S.A. Cutaneous manifestations of endocrine disorders: a guide for dermatologists. Am J Clin Dermatol 4 (2003) 315-331
45. Jara L.J., Lavalle C., Fraga A., et al. Prolactin, immunoregulation, and autoimmune diseases. Semin Arthritis Rheum 20 (1991) 273-284
46. Russell D.H., Kibler R., Matrisian L., et al. Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol 134 (1985) 3027-3031
47. Buskila D., Sukenik S., and Shoenfeld Y. The possible role of prolactin in autoimmunity. Am J Reprod Immunol 26 (1991) 118-123
48. Girolomoni G., Phillips J.T., and Bergstresser P.R. Prolactin stimulates proliferation of cultured human keratinocytes. J Invest Dermatol 101 (1993) 275-279
49. Giasuddin A.S.M., El-Sherif A.I., and El-Ojali S.I. Prolactin: does it have a role in the pathogenesis of psoriasis. Dermatology 197 (1998) 119-122
50. Carr B.R. Disorders of the ovaries and female reproductive tract. In: Wilson J.D., Foster D.W., Kronenberg H.M., et al. (Eds). Williams textbook of endocrinology. 9th ed. (1998), WB Saunders, Philadelphia 795-799
51. Taylor A.E. Polycystic ovary syndrome. Endocrinol Metab Clin North Am 27 (1998) 877-902
52. Regana M.S., and Millet P.U. Psoriasis in association with prolactinoma: three cases. Br J Dermatol 143 (2000) 864-867
53. Molitch M.E., Thorner M.O., and Wilson C.B. Management of prolactinomas: overview and introduction. J Clin Endocrinol Metab 82 (1997) 996-1000
54. Zikel O.M., Atkinson J.L.D., and Hurley D.L. Prolactinoma manifesting with symptomatic hydrocephalus. Mayo Clin Proc 74 (1999) 475-477
55. Saeed S., Farooqi O.A., Panayiotou B., et al. Reversible confusional state in an elderly man. Postgrad Med J 75 (1999) 365-366
56. Iglesias P., Macho L.P., and Diez J.J. Resolution of macroprolactinoma-induced symptomatic hydrocephalus following cabergoline therapy. Age Ageing 33 (2004) 410-412
57. Liu J.K., and Couldwell W.T. Contemporary management of prolactinomas. Neurosurg Focus 16 (2004) E2
58. Vance M.L. Hypopituitarism. N Engl J Med 330 (1994) 1651-1662
59. Daughaday W.H. The anterior pituitary. In: Wilson J.D., and Foster D.W. (Eds). Textbook of endocrinology. 7th ed. (1985), WB Saunders, Philadelphia 568-613
60. Freinkel R.K., and Freinkel N. Dermatologic manifestations of endocrine diseases. In: Fitzpatrick T.B., Eisen A.Z., Wolf K., et al. (Eds). Dermatology in general medicine. 3rd ed. (1986), McGraw-Hill, New York 2063-2081